Zr-89-trastuzumab PET visualises HER2 downregulation by the HSP90 inhibitor NVP-AUY922 in a human tumour xenograft

T.H.O. Munnink, M.A. de Korte, W.B. Nagengast, H. Timmer-Bosscha, C.P. Schroder, J.R. de Jong, G.A.M.S. van Dongen, M.R. Jensen, C. Quadt, M.N. Lub-de Hooge, E.G.E. de Vries

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)678-684
JournalEuropean Journal of Cancer
Volume46
Issue number3
DOIs
Publication statusPublished - 2010

Cite this

Munnink, T. H. O., de Korte, M. A., Nagengast, W. B., Timmer-Bosscha, H., Schroder, C. P., de Jong, J. R., ... de Vries, E. G. E. (2010). Zr-89-trastuzumab PET visualises HER2 downregulation by the HSP90 inhibitor NVP-AUY922 in a human tumour xenograft. European Journal of Cancer, 46(3), 678-684. https://doi.org/10.1016/j.ejca.2009.12.009